Related Experiment Video
Updated: Jul 13, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia
Benjamin J Thompson1, Silvia Buonamici, Maria Luisa Sulis
1Department of Pathology, New York University School of Medicine, New York, NY 10016, USA.
Abstract:
Recent studies have shown that activating mutations of NOTCH1 are responsible for the majority of T cell acute lymphoblastic leukemia (T-ALL) cases. Most of these mutations truncate its C-terminal domain, a region that is important for the NOTCH1 proteasome-mediated degradation. We report that the E3 ligase FBW7 targets NOTCH1 for ubiquitination and degradation. Our studies map in detail the amino acid degron sequence required for NOTCH1-FBW7 interaction. Furthermore, we identify inactivating FBW7 mutations in a large fraction of human T-ALL lines and primary leukemias. These mutations abrogate the binding of FBW7 not only to NOTCH1 but also to the two other characterized targets, c-Myc and cyclin E. The majority of the FBW7 mutations were present during relapse, and they were associated with NOTCH1 HD mutations. Interestingly, most of the T-ALL lines harboring FBW7 mutations were resistant to gamma-secretase inhibitor treatment and this resistance appeared to be related to the stabilization of the c-Myc protein. Our data suggest that FBW7 is a novel tumor suppressor in T cell leukemia, and implicate the loss of FBW7 function as a potential mechanism of drug resistance in T-ALL.
Insights
The E3 ligase FBW7 targets NOTCH1 for degradation in T cell acute lymphoblastic leukemia (T-ALL). Inactivating FBW7 mutations are found in T-ALL, leading to drug resistance and suggesting FBW7 is a tumor suppressor.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Activating NOTCH1 mutations drive most T cell acute lymphoblastic leukemia (T-ALL) cases.
- These mutations often truncate NOTCH1, affecting its degradation.
- The C-terminal domain of NOTCH1 is crucial for its proteasomal degradation.
Purpose of the Study:
- To investigate the role of the E3 ligase FBW7 in NOTCH1 degradation.
- To identify FBW7 mutations in T-ALL and assess their functional consequences.
- To explore the link between FBW7 mutations, NOTCH1, c-Myc, cyclin E, and drug resistance in T-ALL.
Main Methods:
- Mapping the amino acid degron sequence for NOTCH1-FBW7 interaction.
- Screening human T-ALL cell lines and primary leukemias for FBW7 mutations.
- Analyzing the effect of FBW7 mutations on NOTCH1, c-Myc, and cyclin E binding.
- Assessing drug resistance in T-ALL lines with FBW7 mutations, particularly to gamma-secretase inhibitors.
Main Results:
- FBW7 directly targets NOTCH1 for ubiquitination and proteasomal degradation.
- Inactivating FBW7 mutations were identified in a significant proportion of T-ALL samples.
- These mutations impaired FBW7 binding to NOTCH1, c-Myc, and cyclin E.
- FBW7 mutations, often found at relapse and associated with NOTCH1 mutations, conferred resistance to gamma-secretase inhibitors, linked to c-Myc stabilization.
Conclusions:
- FBW7 acts as a tumor suppressor in T cell leukemia by degrading NOTCH1.
- Loss of FBW7 function contributes to T-ALL development and progression.
- FBW7 mutations represent a mechanism of drug resistance in T-ALL, particularly to gamma-secretase inhibitors.
Related Concept Videos
Anaphase Promoting Complex
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

